Speaker illustration

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)

Member of:

European Society of Cardiology

Peter Libby, MD, is a cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, and holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. He actively practices general and preventive cardiology and vascular medicine. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. He conducts basic and translational research in cardiovascular diseases focusing on inflammatory aspects and vascular biology. Dr. Libby has a particular devotion to translate his basic laboratory studies to pilot and then large-scale clinical cardiovascular outcome trials. Dr. Libby has received numerous awards and recognitions for his research accomplishments, and has received a number of lifetime achievement awards from various organizations.

The EHJ’s year in heart failure, ischaemic heart disease and acute cardiovascular care, dyslipidaemias

Event: ESC Congress 2024

Topic: European Society of Cardiology

Session type: Special Session

Thumbnail

Evolution of coronary artery disease diagnosis ... from stenosis to inflammation

Event: ESC Congress 2024

Topic: Coronary Computed Tomography Angiography (Coronary CTA, CCTA)

Session type: Satellite Symposium

Thumbnail

Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease

Event: ESC Congress 2024

Topic: European Society of Cardiology

Session type: Late-Breaking Science

Thumbnail

Inflammation as key driver of vascular dysfunction

Event: ESC Congress 2023

Topic: Vascular Biology and Physiology

Session type: Moderated ePosters

Thumbnail

Improving the management of patients with atherosclerotic cardiovascular disease: the evolving role of icosapent ethyl

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session type: Satellite Symposium

Thumbnail

Vascular disease and perturbed lipid metabolism

Event: ESC Congress 2023

Topic: Lipids, Metabolism

Session type: Moderated ePosters

Thumbnail

Inflammation in atherosclerotic cardiovascular disease (ASCVD): the spark before the fire?

Event: ESC Congress 2022

Topic: Inflammation and Immunity

Session type: Satellite Symposium

Thumbnail

The EHJ’s Year in Cardiovascular Medicine 2020: heart failure, valvular heart disease, imaging

Event: ESC Congress 2021 - The Digital Experience

Topic: Training and Education

Session type: Official Joint Session

Thumbnail

Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglycerides

Event: ESC Congress 2021 - The Digital Experience

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium

Thumbnail

Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides

Event: ESC Congress 2020

Topic: Secondary Prevention

Session type: Industry Q&A session

Thumbnail